Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three ...

GUILDFORD, SURREY / ACCESSWIRE / November 13, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative ... of circulating tumour cells isolated from metastatic ...

New analysis from the DETECT-A study supports MCED testing as a complement to current guideline-recommended screening in lung ...

Q3 2024 Earnings Call Transcript November 6, 2024 MDxHealth SA misses on earnings expectations. Reported EPS is $-0.4 EPS, ...

I don’t see how saliva would have anything to do with your prostate gland. How does the test work, and how can I get access to it? Dear Reader: A test that analyzes bodily fluids is known as a liquid ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisor, ...

These findings will be presented at the American Association for Cancer Research Special Conference in Cancer Research: Liquid Biopsy from November 13-16 ... When excluding breast and prostate cancer ...

“Prostate cancer is mostly a disease of copy number change,” says Attard. That means that following disease progression from liquid biopsy samples is not as straightforward as tracking point m ...

and prostate," said Buonomo. "Although our patient cohort was small, it lays the groundwork for development of a type of 'non-invasive liquid biopsy' that will be used to track the progression of ...

and prostate," said Buonomo. "Although our patient cohort was small, it lays the groundwork for development of a type of 'non-invasive liquid biopsy' that will be used to track the progression of ...